🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In a recent study, up to 15% of patients who received melanoma diagnoses carried mutations in cancer susceptibility genes: cle.clinic/4bgWuZR

The Society For Melanoma Research meeting is coming up - New Orleans in October is a good place to be, with an excellent lineup of speakers. Registrations still available: smrcongress.org

Today, the MRA family is thinking of all who are grieving loved ones. #NeverForget

MRA was honored to attend The Wayne Stinchcomb Big Orange Foundation's 15th Annual Bull Roast in Baltimore this past weekend where we all came together to celebrate Wayne Stinchcomb's memory and continue his legacy by raising funds for melanoma research. THANK YOU to all

#ESMO24 | #Melanoma: why we choose #neoadjuvant immunotherapy? Here are Sapna’s reasons 👇🏼 ESMO - Eur. Oncology Sapna Patel Christian Blank Paolo A. Ascierto

Join Moffitt’s Nikhil Khushalani, MD (Nikhil Khushalani) tomorrow at #ESMO24 for a discussion on the first in-human study of 225Ac-MTI-201 as a novel therapy for metastatic uveal #melanoma during the poster session. ⏰: 9/14 12 p.m. CEST 📍: Hall 6 Learn more ➡️

Collectively, these papers provide mechanistic insight into how PD1 and LAG3 function alone and in combination and highlight opportunities for further clinical development.

An important message!

At #ESMO24, Nikhil Khushalani, MD (Nikhil Khushalani) is presenting the preliminary results of a novel therapy for metastatic uveal melanoma. Read more: bit.ly/4e2DOzi ESMO - Eur. Oncology #CancerResearch

As part of our partnership with American Cancer Society 🇺🇸Journals, OncoAlert 🚨Proudly presents CANCER Section Editor Jason Luke, MD, FACP who presented presents original research during the #melanoma mini oral session at #ESMO24 Revisit his article cowritten with Adnan Khattak on the

Original Article: Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma (CheckMate 067) nej.md/4dUqm0g #ESMO24 | ESMO - Eur. Oncology

This is almost beyond imagination. During my oncology fellowship, ppl w/ newly diagnosed metastatic #melanoma lived ~ 6m on avg. Now we have many ppl alive AND cancer-free a decade later. We aren’t done yet, but #ScienceWillWin. Bet. 💪🏆 #OncTwitter #melsm #HistoryofMedicine

MD Anderson and collaborators initiate space project to explore T cell behavior in microgravity msn.com/en-gb/health/o…

Approximately 100,000 people in the U.S. will be diagnosed with melanoma this year, according to the American Cancer Society. A new treatment for advanced melanoma is called tumor-infiltrating lymphocyte therapy (TIL therapy). Learn more: mayocl.in/4eqs1dL

"At the time of my diagnosis, I was a fairly young woman, and, frankly, didn’t feel comfortable pushing my doctor harder. After the diagnosis, I was really frustrated and upset. That’s when I started to realize I needed to be proactive in all aspects of my health, including who I